Studies have shown that the occurrences of HLA-A*02, HLA-B*12-HLA-Cw*05, and HLA-A*02-HLA-B*44-HLA-Cw*05 are associated with a reduced risk of developing MS [85,86,87]. This evidence concerns the gene HLA-A and myeloid sarcoma.